Brightline Health vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Brightline is a virtual behavioral health platform for children, teens, and families providing therapy, coaching, and psychiatry through employer and health plan benefits.
About
Brightline is a virtual pediatric and family behavioral health company founded in 2019 that has raised over $100M to address the severe shortage of mental health care for children and adolescents. The platform offers a comprehensive range of virtual services including therapy, behavioral coaching, and child psychiatry for children from infancy through young adulthood, with services designed to match each family's specific clinical needs. Brightline distributes primarily through employer benefits programs and health insurance plans, making its services accessible to families through their existing healthcare coverage. The company employs licensed clinical therapists, coaches, and psychiatrists who deliver care via video, messaging, and care coordination tools. Brightline uses technology to reduce waitlist times that commonly afflict in-person pediatric mental health providers, which can stretch to months in many markets. The company has established partnerships with major health plans and large employers to bring family behavioral health benefits to millions of covered lives. As awareness of the pediatric mental health crisis has grown following the pandemic, Brightline has emerged as a leader in tech-enabled pediatric behavioral health.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.